Frank Pasqualone has an estimated net worth of $11 Million. This is based on reported shares across multiple companies, which include THERAVANCE INC, Theravance Biopharma, Inc., and Enveric Biosciences, Inc..
2014 was Frank Pasqualone's most active year for acquiring shares with 3 total transactions. Frank Pasqualone's most active month to acquire stocks was the month of January. 2017 was Frank Pasqualone's most active year for disposing of shares, totalling 4 transactions. Frank Pasqualone's most active month to dispose stocks was the month of January. 2017 saw Frank Pasqualone paying a total of $105,358.80 for 13,000 shares, this is the most they've acquired in one year. In 2020 Frank Pasqualone cashed out on 37,034 shares for a total of $893,442.20, their largest year based on trade value.